|1.||Blight, A R: 1 article (09/2014)|
|2.||Gay, E A: 1 article (09/2014)|
|3.||Heyes, M P: 1 article (09/2014)|
|4.||Yates, J R: 1 article (09/2014)|
|5.||Yates, Jennifer R: 1 article (06/2006)|
|6.||Blight, Andrew R: 1 article (06/2006)|
|7.||Heyes, Melvyn P: 1 article (06/2006)|
|1.||Spinal Cord Injuries (Spinal Cord Injury)
01/01/1996 - "4-Chloro-3-hydroxyanthranilate is a potent inhibitor of QUIN production by macrophages and reduces QUIN accumulations in spinal cord injury. "
09/01/2014 - "Effects of methylprednisolone and 4-chloro-3-hydroxyanthranilic acid in experimental spinal cord injury in the guinea pig appear to be mediated by different and potentially complementary mechanisms."
06/01/2006 - "4-chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury."
09/01/2014 - "Blinded, placebo-controlled, parallel treatment group studies of the effects of methylprednisolone (MP) or 4-chloro-3-hydroxyanthranilate (4-Cl-3-HAA) on behavioral outcome and quinolinic acid tissue levels from experimental thoracic spinal cord injury in adult guinea pigs. "
|2.||Transient Ischemic Attack
|3.||Brain Diseases (Brain Disorder)